Mast cell proteases

被引:251
作者
Pejler, Gunnar [1 ]
Abrink, Magnus [1 ]
Ringvall, Maria [1 ]
Wernersson, Sara [1 ]
机构
[1] Swedish Univ Agr Sci, Ctr Biomed, Dept Anat Physiol & Biochem, Uppsala, Sweden
来源
ADVANCES IN IMMUNOLOGY, VOL 95 | 2007年 / 95卷
关键词
D O I
10.1016/S0065-2776(07)95006-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mast cells (MCs) are traditionally thought of as a nuisance for its host, for example, by causing many of the symptoms associated with allergic reactions. In addition, recent research has put focus on MCs for displaying harmful effects during various autoimmune disorders. On the other hand, MCs can also be beneficial for its host, for example, by contributing to the defense against insults such as bacteria, parasites, and snake venom toxins. When the MC is challenged by an external stimulus, it may respond by degranulation. In this process, a number of powerful preformed inflammatory "mediators" are released, including cytokines, histamine, serglycin proteoglycans, and several MC-specific proteases: chymases, tryptases, and carboxypeptidase A. Although the exact effector mechanism(s) by which MCs carry out their either beneficial or harmful effects in vivo are in large parts unknown, it is reasonable to assume that these mediators may contribute in profound ways. Among the various MC mediators, the exact biological function of the MC proteases has for a long time been relatively obscure. However, recent progress involving successful genetic targeting of several MC protease genes has generated powerful tools, which will enable us to unravel the role of the MC proteases both in normal physiology as well as in pathological settings. This chapter summarizes the current knowledge of the biology of the MC proteases.
引用
收藏
页码:167 / 255
页数:89
相关论文
共 430 条
[81]   Mast cell tissue inhibitor of metalloproteinase-1 is cleaved and inactivated extracellularly by α-chymase [J].
Frank, BT ;
Rossall, JC ;
Caughey, GH ;
Fang, KC .
JOURNAL OF IMMUNOLOGY, 2001, 166 (04) :2783-2792
[82]   Proliferative action of mast-cell tryptase is mediated by PAR2, COX2, prostaglandins, and PPARγ:: Possible relevance to human fibrotic disorders [J].
Frungieri, MB ;
Weidinger, S ;
Meineke, V ;
Köhn, FM ;
Mayerhofer, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (23) :15072-15077
[83]  
Fukami H, 2000, Drug Des Discov, V17, P69
[84]   Association of a mast cell chymase gene variant with HDL cholesterol, but not with blood pressure in the Ohasama study [J].
Fukuda, M ;
Ohkubo, T ;
Katsuya, T ;
Hozawa, A ;
Asai, T ;
Matsubara, M ;
Kitaoka, H ;
Tsuji, I ;
Araki, T ;
Satoh, H ;
Higaki, J ;
Hisamichi, S ;
Imai, Y ;
Ogihara, T .
HYPERTENSION RESEARCH, 2002, 25 (02) :179-184
[85]   Human β-tryptase:: Detection and characterization of the active monomer and prevention of tetramer reconstitution by protease inhibitors [J].
Fukuoka, Y ;
Schwartz, LB .
BIOCHEMISTRY, 2004, 43 (33) :10757-10764
[86]   Transcriptional activation of mouse mast cell protease-7 by activin and transforming growth factor-β is inhibited by microphthalmia-associated transcription factor [J].
Funaba, M ;
Ikeda, T ;
Murakami, M ;
Ogawa, K ;
Tsuchida, K ;
Sugino, H ;
Abe, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (52) :52032-52041
[87]   Mast cells as "tunable" effector and immunoregulatory cells: Recent advances [J].
Galli, SJ ;
Kalesnikoff, J ;
Grimbaldeston, MA ;
Piliponsky, AM ;
Williams, CMM ;
Tsai, M .
ANNUAL REVIEW OF IMMUNOLOGY, 2005, 23 :749-786
[88]   Mast cells in the development of adaptive immune responses [J].
Galli, SJ ;
Nakae, S ;
Tsai, M .
NATURE IMMUNOLOGY, 2005, 6 (02) :135-142
[89]   Expansion of the mast cell chymase locus over the past 200 million years of mammalian evolution [J].
Gallwitz, Maike ;
Reimer, Jenny M. ;
Hellman, Lars .
IMMUNOGENETICS, 2006, 58 (08) :655-669
[90]   Rapid lineage-specific diversification of the mast cell chymase locus during mammalian evolution [J].
Gallwitz, Maike ;
Hellman, Lars .
IMMUNOGENETICS, 2006, 58 (08) :641-654